Abstract:Objective To determine the role of hepcidin and related factors in evaluation of iron overload in patients with myelodysplastic syndromes(MDS).Methods Sixty-four patients with MDS were enrolled.The hepcidin levels in peripheral blood and bone marrow were measured by ELISA,the expression of growth differentiation factor 15(GDF15) and twisted gastrulation 1(TWSG1) mRNA was detected by Real-Time PCR,T lymphocyte subtypes(CD4~+ and CD19~+ lymphocytes) and T lymphocyte polarization were determined by flow cytometry,the deposition of iron in heart and liver was examined through magnetic resonance imaging T2(MRI T2 ),and serum ferritin(SF),C-reactive protein(CRP) and erythropoietin(EPO) levels were measured.Results There was no significant difference between hepcidin level in peripheral blood and that in bone marrow(P=0.134).Stratified according to WHO 2008 subtypes,the hepcidin level in patients with refractory anemia with ringed sideroblasts(RARS) was the lowest[(105.40±5.13) ng/mL],and that in patients with refractory anemia with excess blasts(RAEB) was the highest[(335.71±25.16) ng/mL],and there were significant differences among groups(P =0.041).Stratified according to IPSS and WPSS,there were significant differences in hepcidin levels between low-risk group and high-risk group in two systems respectively(P<0.05 and P<0.01).The SF level and expression of GDF15 mRNA in WPSS high-risk group were significantly higher than those in WPSS low-risk group (P<0.05),while there was no significant difference between IPSS low-risk group and IPSS high-risk group(P>0.05). Stratified according to T lymphocyte subtype and polarization,the hepcidin level in CD4~+ high-expression group was higher than that in normal expression group(P<0.05),but there was no significant difference in the hepcidin levels between CD19~+ high-expression group and normal expression group(P =0.206),and the hepcidin level in Thl/Th2>70.6 group was higher than that in Thl/Th2≤70.6 group(P<0.001).Stepwise regression analysis revealed that liver iron concentration (LIC,measured by MRI T2"),instead of SF and cardiac T2~*,was correlated with hepcidin(r =0.582,P<0.001). Conclusion Inflammation has a significant impact on hepcidin expression,and the activation and polarization of T lymphocytes may partially participate in the mechanism.T2~* MRI outperformed SP in evaluation of iron overload in patients with MDS.

Pro-hepcidin,its Detection and the Clinic Discussion in the Anemia of Chronic Renal Failure

The Measurement and Clinical Significance of Pro-hepcidin in Patients Having Renal Anemic Before and after Renal Transplantation

Serum Hepcidin in Haemodialysis Patients: Associations with Iron Status and Microinflammation.

Serum hepcidin is associated with iron status and micro-inflammation in hemodialysis patients

Advance in Hepcidin

Changes of Hepcidin During Anemia Treatment in Patients on Maintenance Hemodialysis

Recent progress in diagnosis applications of hepcidin in human disorders

Clinical Significance of Serum Hepcidin in the Diagnosis and Treatment of Patients with Anemia of Chronic Disease: a Meta-Analysis

In-depth review: is hepcidin a marker for the heart and the kidney?

Study of the hepcidin level in pregnant women with and without anemia

Hepcidin as a Potential Biomarker for the Diagnosis of Anemia

Iron-Refractory Iron Deficiency Anemia: New Molecular Mechanisms

Hepcidin-25 in patients with deep fungal infections and its clinical significance

Study of hepcidin level in bone marrow in patients with myelodysplastic syndromes

Serum Hepcidin-25 and All-Cause Mortality in Patients Undergoing Maintenance Hemodialysis

Hepcidin: from discovery to differential diagnosis

[Research advances of hepcidin expression and its regulation mechanism].

Could Hepcidin Be a New Biomarker in Patients with Idiopathic Pulmonary Fibrosis (IPF)?

Reciprocal Regulation Between Hepcidin and Erythropoiesis and Its Therapeutic Application in Erythroid Disorders

Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization

Change in iron metabolism in rats after renal ischemia/reperfusion injury